Spring is here, and with it comes news of a new and vicious ransomware attack, known as LockerGoga.
The top risk cyberattackers face is the risk of getting caught. But executing an attack is typically a labor-intensive process. Attackers also worry that the access they’ve worked so hard to establish might suddenly get cut off if a password gets changed or an account they’re using is retired or removed from the domain.
On February 13th, we broke out the hats and balloons (read: hummus and beer) to celebrate Illusive’s 100th software sprint. For 100 releases now, we’ve been helping our customers—hundreds of organizations across industries—revolutionize their ability to stop advanced cyberattackers.
Let’s tackle a familiar, yet daunting problem for vulnerability management (VM) teams: The patching “to-do” list in most organizations is so long that having some way to prioritize patching of networked endpoints, servers and other assets is essential for limiting exposure to cyberattacks.
HIPAA Compliance—Cyberattackers Aren’t Fazed
In spite of longstanding HIPAA compliance requirements, and the billions of dollars being invested to ensure HIPAA compliance, it seems that cyberthreats and attackers aren't fazed. Healthcare suffered from some of the largest breaches ever reported in 2015. The breach at Anthem compromised 78.8 million records, and two additional breaches exposed more than 10 million records each1. The following year, 2016, saw the highest number of breaches with 327 reported. The number of breaches in 2017 surpassed 2016, with more than 342 reported. While the number of breaches grew, the number of compromised records dropped from 112 million in 2016 to a little more than 14 million in 2017.
More than $2.5 trillion in mergers were announced in the first half of 2018—a new record. Ranked by value of the deal, energy and power deals led, followed by media and entertainment, with healthcare and industrials close behind. Industries are converging and organizations are using acquisitions, divestitures, and other forms of asset remix to reposition their businesses. For example, there are numerous mergers among pharmaceutical, life sciences, and biotech companies as they seek to gain traction in a highly fragmented market. EY predicts that the total value of life sciences M&A will surpass $200 billion in 2018. According to Deloitte, technology acquisition is the primary driver of M&A pursuits, ahead of expanding customer bases in existing markets, and adding products or services.